$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Predictive Factors for Delayed Virologic Response of Adefovir Add-on Therapy in Lamivudine-resistant Chronic Hepatitis B

Soonchunhyang Medical Science : SMS, v.19 no.1, 2013년, pp.10 - 16  

Baek, Ae Rin ,  Kim, Dae Yong ,  Kim, Young Seok ,  Kim, Sang Gyune ,  Kim, Jung Hyun ,  Kim, Min Suk ,  Kim, Tae Jin ,  Lee, Yun Nah ,  Lee, Sae Hwan ,  Jeong, Soung Won ,  Jang, Jae Young ,  Kim, Hong Soo ,  Kim, Boo Sung

초록이 없습니다.

참고문헌 (25)

  1. Lai, Ching‐Lung, Dienstag, Jules, Schiff, Eugene, Leung, Nancy W. Y., Atkins, Mark, Hunt, Christine, Brown, Nathaniel, Woessner, Mary, Boehme, Richard, Condreay, Lynn. Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.36, no.6, 687-696.

  2. Lee, Jung Min, Park, Jun Yong, Kim, Do Young, Nguyen, Tin, Hong, Sun Pyo, Kim, Soo Ok, Chon, Chae Yoon, Han, Kwang-Hyub, Ahn, Sang Hoon. Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B. Antiviral therapy, vol.15, no.2, 235-241.

  3. Kim, Hong Joo, Park, Jung Ho, Park, Dong Il, Cho, Yong Kyun, Sohn, Chong Il, Jeon, Woo Kyu, Kim, Byung Ik. Rescue therapy for lamivudine-resistant chronic hepatitis B: Comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy. Journal of gastroenterology and hepatology, vol.25, no.8, 1374-1380.

  4. Ryu, Han Jak, Lee, Jung Min, Ahn, Sang Hoon, Kim, Do Young, Lee, Myoung Ha, Han, Kwang-Hyub, Chon, Chae Yoon, Park, Jun Yong. Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B. Journal of medical virology, vol.82, no.11, 1835-1842.

  5. Chung, Goh Eun, Kim, Won, Lee, Kook Lae, Hwang, Sang Youn, Lee, Jeong-Hoon, Kim, Hwi Young, Jung, Yong Jin, Kim, Donghee, Jeong, Ji Bong, Kim, Byeong Gwan, Kim, Yoon Jun, Yoon, Jung-Hwan, Lee, Hyo-Suk. Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B. Digestive diseases and sciences, vol.56, no.7, 2130-2136.

  6. Sheng, Yun-Jian, Liu, Jun-Ying, Tong, Shi-Wen, Hu, Huai-Dong, Zhang, Da-Zhi, Hu, Peng, Ren, Hong. Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis. Virology journal, vol.8, no.1, 393-393.

  7. Lee, Sun Jae, Yim, Hyung Joon, Hwang, Seong Gyu, Seo, Yeon Seok, Kim, Ji Hoon, Yoon, Eileen L., Lee, Joong Min, Kim, Bo Hyun, Park, Sang Jong, Park, Young Min, Kim, Hong Soo, Lee, Se Hwan, Ahn, Sang Hoon, Lee, Jeong Il, Lee, Jin Woo, Kim, In Hee, Kim, Hyung Soo, Hong, Sun Pyo. Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study. Scandinavian journal of gastroenterology, vol.48, no.2, 196-204.

  8. orea, GeneMarix Inc., Yongin, Korea, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea. Adding adefovir vs. switching to entecavir for lamivudine‐resistant chronic hepatitis B (ACE study): a 2‐year follow‐up randomized controlled trial. Liver international : official journal of the International Association for the Study of the Liver, vol.33, no.2, 244-254.

  9. KASL clinical practice guidelines: management of chronic hepatitis B 109 2012 

  10. Ong, A., Wong, V. W.‐S., Wong, G. L.‐H., Chan, H.‐Y., Tse, C.‐H., Chan, H. L.‐Y.. Management options for lamivudine‐resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir. Alimentary pharmacology & therapeutics, vol.34, no.8, 972-981.

  11. Kim, Yu Jin, Paik, Seung Woon, Sinn, Dong Hyun, Gwak, Geum‐Youn, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Yoo, Byung Chul. Viral response at 6 months is associated with treatment outcome of adefovir add‐on therapy for lamivudine‐resistance. Journal of gastroenterology and hepatology, vol.27, no.9, 1454-1460.

  12. Seto, Wai-Kay, Liu, Kevin, Fung, James, Wong, Danny Ka-Ho, Yuen, John Chi-Hang, Hung, Ivan Fan-Ngai, Lai, Ching-Lung, Yuen, Man-Fung. Outcome of Lamivudine-Resistant Chronic Hepatitis B after up to 5 Years of Combination Therapy with Adefovir. Antiviral therapy, vol.17, no.7, 1255-1262.

  13. Lok, Anna S.F, Lai, Ching-Lung, Leung, Nancy, Yao, Guang-Bi, Cui, Zhen-Yu, Schiff, Eugene R, Dienstag, Jules L, Heathcote, E.Jenny, Little, Nancy R, Griffiths, Dorothea A, Gardner, Stephen D, Castiglia, Mary. Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology, vol.125, no.6, 1714-1722.

  14. Allen, Marchelle I., Deslauriers, Manon, Andrews, C. Webster, Tipples, Graham A., Walters, Kathie-Anne, Tyrrell, David L., Brown, Nathaniel, Condreay, Lynn D.. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.27, no.6, 1670-1677.

  15. Lampertico, P., Marzano, A., Levrero, M., Santantonio, T., Di Marco, V., Brunette, M., Andreone, P., Sagnelli, E., Faguioli, S., Mazzella, G.. [502] ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY IS SUPERIOR TO ADEFOVIR MONOTHERAPY FOR LAMIVUDINE-RESISTANT PATIENTS WITH HBeAg-NEGATIVE CHRONIC HEPATITIS B. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.46, no.suppl1, S191-.

  16. Toyama, Takashi, Ishida, Hisashi, Ishibashi, Hiromi, Yatsuhashi, Hiroshi, Nakamuta, Makoto, Shimada, Masaaki, Ohta, Hajime, Satoh, Takeaki, Kato, Michio, Hijioka, Taizo, Takano, Hirotsugu, Komeda, Toshiki, Yagura, Michiyasu, Mano, Hiroshi, Watanabe, Yukio, Kobayashi, Masakazu, Mita, Eiji. Long‐term outcomes of add‐on adefovir dipivoxil therapy to ongoing lamivudine in patients with lamivudine‐resistant chronic hepatitis B. Hepatology research : the official journal of the Japan Society of Hepatology, vol.42, no.12, 1168-1174.

  17. Chae, Hee Bok, Kim, Mee Jin, Seo, Eui Geun, Choi, Yong Hyeok, Lee, Hee Seung, Han, Joung Ho, Yoon, Soon Man, Park, Seon Mee, Youn, Sei Jin. High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B. The Korean journal of hepatology, vol.18, no.1, 75-83.

  18. Ha, Minghao, Zhang, Guotong, Diao, Shu, Lin, Mingfang, Wu, Jianqiu, Sun, Liping, She, Huiyuan, Shen, Lihui, Huang, Chunhong, Shen, Wenjuan, Huang, Zhongming. Rescue Therapy for Lamivudine-resistant Chronic Hepatitis B: Adefovir Monotherapy, Adefovir Plus Lamivudine or Entecavir Combination Therapy. Internal medicine, vol.51, no.12, 1509-1515.

  19. Zhao, P., Wang, C., Huang, L., Xu, D., Li, T.. Comparison of rescue strategies in lamivudine-resistant patients with chronic hepatitis B. Antiviral research, vol.96, no.2, 100-104.

  20. Cho, Yuri, Lee, Dong Hyeon, Chung, Kwang Hyun, Jin, Eunhyo, Lee, Jeong-Hoon, Cho, Eun Ju, Yu, Su Jong, Kim, Jin Wook, Jeong, Sook Hyang, Yoon, Jung-Hwan, Lee, Hyo-Suk, Kim, Chung Yong, Kim, Yoon Jun. The Efficacy of Adefovir Plus Entecavir Combination Therapy in Patients with Chronic Hepatitis B Refractory to Both Lamivudine and Adefovir. Digestive diseases and sciences, vol.58, no.5, 1363-1370.

  21. Shin, Su Rin, Koh, Kwang Cheol, Gwak, Geum-Youn, Choi, Moon Seok, Lee, Joon Hyoek, Paik, Seung Woon, Yoo, Byung Chul. A Low Viral Load Predicts a Higher Initial Virologic Response to Adefovir in Patients with Lamivudine-Resistant Chronic Hepatitis B. Gut and liver, vol.4, no.4, 530-536.

  22. Kim, Hong J., Park, Jung H., Park, Dong I., Cho, Yong K., Sohn, Chong I., Jeon, Woo K., Kim, Byung I.. The influence of YMDD mutation patterns on clinical outcomes in patients with adefovir add‐on lamivudine combination treatment. Liver international : official journal of the International Association for the Study of the Liver, vol.32, no.2, 303-310.

  23. You, Hong, Wu, Xiaoning, Ou, Xiaojuan, Ma, Hong, Wang, Qianyi, Liu, Tianhui, Cong, Min, Wang, Ping, Wang, Baoen, Jia, Jidong. Two Patterns of Alanine Aminotransferase Increase to Predict Long-Term Viral Response in Chronic Hepatitis B Patients: Virus- or Host-Induced?. Antiviral therapy, vol.16, no.3, 299-307.

  24. Aizawa, Mashu, Tsubota, Akihito, Fujise, Kiyotaka, Tatsuzawa, Keiko, Kono, Midori, Hoshina, Sadayori, Tajiri, Hisao. Clinical course and predictive factors of virological response in long‐term lamivudine plus adefovir dipivoxil combination therapy for lamivudine‐resistant chronic hepatitis B patients. Journal of medical virology, vol.83, no.6, 953-961.

  25. Kim, Yu Jin, Sinn, Dong Hyun, Gwak, Geum-Youn, Choi, Moon Seok, Koh, Kwang Cheol, Paik, Seung Woon, Yoo, Byung Chul, Lee, Joon Hyeok. Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures.. World journal of gastroenterology : WJG, vol.18, no.47, 6996-7002.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로